DataMEDS AI, Inc. (MEDS)
| Market Cap | 9.68M -90.7% |
| Revenue (ttm) | 8.02M -78.2% |
| Net Income | -88.28M |
| EPS | -43.73 |
| Shares Out | 3.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,882,187 |
| Open | 0.895 |
| Previous Close | 0.865 |
| Day's Range | 0.865 - 3.850 |
| 52-Week Range | 0.823 - 75.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 17, 2026 |
About MEDS
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as We... [Read more]
Financial Performance
In 2025, DataMEDS AI's revenue was $23.34 million, an increase of 28.73% compared to the previous year's $18.13 million. Losses were -$101.27 million, 1377.1% more than in 2024.
Financial StatementsNews
Axe Compute sells Helomics to DataMEDS AI, terms undisclosed
Axe Compute (AGPU) announced the sale of its legacy artificial intelligence cancer diagnostics laboratory business Helomics to DataMEDS AI (MEDS). Under the agreement, Axe Compute sold its wholly-owne...
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App TAMPA, FL / A...
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
50% off available online at www.TolloHealth.Shop and www.CorexaRx.com Soon to become available at Health Lives Here™ pharmacies and on Amazon.com TAMPA, FL / ACCESS Newswire / August 27, 2026 / Dat...
DataMEDS AI reports Q2 EPS ($7.13) vs. ($5.40) last year
Reports Q2 revenue $1.78M vs. $7,8M last year. “Having been in leadership now for just under three months, I am excited with the significant progress we are making towards the…
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
Revenues grew 14% reaching $1.779M in Q2/26, beating management projections Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from...
DataMEDS AI provides update on Corexa Pharmacy
DataMeds AI (MEDS) provided an update on the Company’s pharmaceuticals-focused subsidiary Corexa Health’s pharmacy division Corexa Pharmacy. The company said, “Corexa Pharmacy recently achieved severa...
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026
TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure ...
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
GLP-1 agonist drugs now available Integration of online store CorexaRx.com into Health Lives Here app now complete Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available R...
DataMEDS AI renames pharmacy subsidiaries under Corexa Health division
DataMeds AI (MEDS) announced that it has completed the name changes of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy and Corexa Tech & Hub, respectively. Corexa Pharmacy and…
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform Einst...
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform Einste...
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patie...
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company"...
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVL...
Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
PHILADELPHIA--(BUSINESS WIRE)---- $DVLT #DatavaultAI--Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real-w...
DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
TAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a health information technology leader implementing EinsteinRx™ artificial intelligence pr...
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NAS...
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellg...
Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescripti...
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
Rubenstein PR named AOR for Wellgistics Health (WGRX) to launch its AI Healthcare ecosystem, expanding EinsteinRx & PharmacyChain for advanced Health IT.
Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics")...
Wellgistics Health Executive Chairman and President Exercise Warrants
Executives exercise previously issued warrants to acquire 200,000 common shares Shares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 20...
DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect patients' digital health twins in t...
Wellgistics Health Provides Mid-Year 2026 Corporate Outlook
Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progress Recent capital raise provides capital into la...
Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock
Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, in...